Baseline demographics of study cohort
| Number | % | ||
|---|---|---|---|
| Sex | Male | 61 | 57 |
| Female | 46 | 43 | |
| Age | Median (months) | 8.4 (SD 10.1) | |
| Range (months) | 0.2–44.0 | ||
| Diagnosis | Sporadic | 97 | 91 |
| Familial | 10 | 9 | |
| Ophthalmic follow up | Mean (months) | 44.3 (SD 20.5) | |
| Range (months) | 8.1–114 | ||
| Laterality | Right | 50 | 47 |
| Left | 57 | 53 | |
| Reese Ellsworth classification | |||
| I | 15 | 14 | |
| II | 7 | 6.5 | |
| III | 56 | 52 | |
| IV | 8 | 7.5 | |
| V | 21 | 20 | |
| Tumour(s) location | Between optic disc and posterior pole | 38 | 36 |
| Between posterior pole and equator | 72 | 67 | |
| Anterior to equator | 62 | 58 | |
| Confluent tumour | 1 | ||
| Subretinal tumour seeds | 4 | 3.7 | |
| Vitreous tumour seeds | 14 | 13 | |
| Primary treatment | Cryotherapy | 15 | 14 |
| Brachytherapy | 4 | 3.7 | |
| Chemotherapy | 11 | 10 | |
| LSRT | 40 | 37 | |
| WERT | 31 | 29 | |
| Diode laser chemothermotherapy (CTT) | 1 | 0.9 | |
| Combined chemotherapy and radiotherapy | 3 | 2.8 | |
| Combined xenon arc and cryotherapy | 1 | 0.9 | |
| Combined cryotherapy and I125 plaque | 1 | 0.9 |